Newer contrast agents for urography.
New low-osmolality ratio-3 contrast media have been shown to have less toxicity than currently used contrast media. In intravenous excretory urography, these agents give significantly higher urinary iodine concentrations, produce less diuresis, and are better tolerated by patients because of fewer unpleasant side effects. These newer low-osmolality contrast media have significant advantages in intravenous urography.
D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects; D002648:Child; D003167:Complement Activation / Q000187:drug effects; D003287:Contrast Media / Q000009:adverse effects; D003973:Diatrizoate; D006321:Heart / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006636:Histamine Release / Q000187:drug effects; D006801:Humans; D007483:Iothalamic Acid; D007485:Ioxaglic Acid; D007668:Kidney / Q000187:drug effects; D008168:Lung / Q000187:drug effects; D008793:Metrizamide; D051379:Mice; D013924:Thrombophlebitis / Q000139:chemically induced; D014283:Triiodobenzoic Acids; D014567:Urography
D003287:Contrast Media; D014283:Triiodobenzoic Acids; D003973:Diatrizoate; D007483:Iothalamic Acid; D008793:Metrizamide; D007485:Ioxaglic Acid